Using our previous molecular subtyping of BC cell lines and histological characterization of clinical specimens as well as genetically engineered mouse models (GEMMs), we characterized HDAC expression in commonly used in vitro and in vivo models of BC. This evidence concerns the gene HDAC9 and breast cancer.